Pharmacokinetic Study of Nanoencapsulated Gel of Lidocaine, Prilocaine and Combination of Lidocaine and Prilocaine
Status:
Completed
Trial end date:
2016-05-06
Target enrollment:
Participant gender:
Summary
This trial evaluated the pharmacokinetic interaction between fixed doses of lidocaine (2.5%),
prilocaine (2.5%) or the association of both (Nanorap®) in healthy volunteers. The drug
safety and tolerability was also evaluated.
Phase:
Phase 1
Details
Lead Sponsor:
Galeno Desenvolvimento de Pesquisas Clínicas
Collaborator:
Biolab Sanus Farmaceutica
Treatments:
EMLA Lidocaine Lidocaine, Prilocaine Drug Combination Prilocaine